Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study-Reference-Cited by-同舟云学术

Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study

Published:2016-02 Issue:10020 Volume:387 Page:770-778
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Dreyling Martin,Jurczak Wojciech,Jerkeman Mats,Silva Rodrigo Santucci,Rusconi Chiara,Trneny Marek,Offner Fritz,Caballero Dolores,Joao Cristina,Witzens-Harig Mathias,Hess Georg,Bence-Bruckler Isabelle,Cho Seok-Goo,Bothos John,Goldberg Jenna D,Enny Christopher,Traina Shana,Balasubramanian Sriram,Bandyopadhyay Nibedita,Sun Steven,Vermeulen Jessica,Rizo Aleksandra,Rule Simon

Publisher

Elsevier BV

Subject

General Medicine

Reference28 articles.

1. Mantle cell lymphoma;Cortelazzo;Crit Rev Oncol Hematol,2012

2. Improvement of overall survival in advanced stage mantle cell lymphoma;Herrmann;J Clin Oncol,2009

3. Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Dreyling;Ann Oncol,2014

4. The current therapeutic scenario for relapsed mantle cell lymphoma;Ferrero;Curr Opin Oncol,2013

5. Guidelines for the investigation and management of mantle cell lymphoma;McKay;Br J Haematol,2012

Cited by 395 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dismantling relapsed/refractory mantle cell lymphoma;Blood Reviews;2024-09

2. Accessing BTK Inhibitors and Other Novel Therapies for Mantle Cell Lymphoma: Are We All Invited to the Party?;Clinical Lymphoma Myeloma and Leukemia;2024-09

3. Ibrutinib-induced spinal haematoma in a patient with marginal zone lymphoma;BMJ Case Reports;2024-08

4. Biological and clinical determinants shaping heterogeneity in mantle cell lymphoma;BLOOD ADV;2024

5. Targeted small molecule therapy and inhibitors for lymphoma;Future Medicinal Chemistry;2024-07-17